NCT02746809 - Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

December 15, 2021

Conditions

Aortic Valve Stenosis

Interventions

DEVICE

CoreValve Evolut 34R TAVR system

"The CoreValve Evolut 34R System is a transcatheter aortic valve implantation system comprised of the following three components:~1. Evolut 34R Transcatheter Aortic Valve (TAV)~2. EnVeo R Delivery Catheter System (DCS) with EnVeo R InLine Sheath~3. EnVeo R Loading System (LS)"

Trial Locations (10)

10016

New York Langone Medical Center, New York

11576

St. Francis Hospital, Roslyn

17104

Pinnacle Health/Moffitt Heart and Vascular Institute, Harrisburg

43214

Riverside Methodist Hospital, Columbus

48109

University of Michigan Health Systems, Ann Arbor

49503

Spectrum Health Hospitals, Grand Rapids

53215

Aurora Health Care/St Luke's Medical Center, Milwaukee

75225

Baylor Heart and Vascular Hospital, Dallas

06520

Yale New Haven Hospital, New Haven

02215

Beth Israel Deaconess Medical Center, Boston